<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39353981</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Preliminary investigation and analysis of nucleotide site variability of nine glycoproteins on varicella-zoster virus envelope, Jilin Province, China, 2010-March 2024.</ArticleTitle><Pagination><StartPage>22758</StartPage><MedlinePgn>22758</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">22758</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-73072-w</ELocationID><Abstract><AbstractText>Varicella is endemic worldwide. In China, varicella has not yet been included in the list of legal infectious diseases, nor has a unified national surveillance program been established. And the live attenuated varicella vaccine has not been included in routine immunization. In this study, we analyzed for the first time the varicella epidemiology in Jilin Province in the past 20 years, and the nucleotide site, amino acid site and N-glycosylation site variation of glycoprotein in varicella-zoster virus (VZV) surface 9 in the past 15 years. The results showed that the reported incidence of varicella in Jilin Province in the last 20 years was fluctuating above and below 20/100,000, especially after the epidemic of the COVID-19, and fatal cases appeared in individual years. The genotypic branching of VZV was monitored as Clade 2 in the last 15 years. 9 glycogen nucleotide sites of VZV had different degrees of variability, and the variability had specificity. Therefore, it gives us the idea that in order to reduce the incidence of varicella and herpes zoster, a provincial or even national surveillance program should be introduced as early as possible, and the dynamic monitoring of the variability of the nucleotide sites of VZV should be strengthened at the same time as the vaccine immunization strategy is introduced.</AbstractText><CopyrightInformation>Â© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiran</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hongyan</LastName><ForeName>Sun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biobank, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guixiang</LastName><ForeName>Qin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Tuberculosis Meningitis Diagnosis and Treatment Center, Changchun Infectious Disease Hospital, Changchun, 130123, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ying</LastName><ForeName>Sun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, 130021, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Viral Disease, Jilin Provincial Center for Disease Control and Prevention, Changchun, 130062, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xin</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of EMO, Jilin Provincial Center for Disease Control and Prevention, Changchun, 130062, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mengying</LastName><ForeName>Han</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Wang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, The Second Hospital of Jilin University, Changchun, 130022, Jilin, China. wji@jlu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shangwei</LastName><ForeName>Ji</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, China. jisw@jlu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023GW005</GrantID><Agency>the Key Laboratory of Viruses of Jilin Provincial Health Commission</Agency><Country /></Grant><Grant><GrantID>20190206</GrantID><Agency>the Vaccination and Immunization Youth Talent Elevation Program of Chinese Preventive Medicine Association</Agency><Country /></Grant><Grant><GrantID>2021YX0547</GrantID><Agency>Horizontal joint project of Jilin University</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006023">Glycoproteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014645" MajorTopicYN="Y">Herpesvirus 3, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014759" MajorTopicYN="Y">Viral Envelope Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002644" MajorTopicYN="N">Chickenpox</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006031" MajorTopicYN="N">Glycosylation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Envelope glycoprotein</Keyword><Keyword MajorTopicYN="N">Mutation site</Keyword><Keyword MajorTopicYN="N">Varicella zoster virus</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>23</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39353981</ArticleId><ArticleId IdType="pmc">PMC11445264</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-73072-w</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-73072-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Breuer, J., Grose, C., Norberg, P., Tipples, G. &amp; Schmid, D. S. A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: Summary of VZV nomenclature meeting 2008, Barts and the London School of Medicine and Dentistry, 24â25 July 2008. J. Gen. Virol.91, 821â828 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2888159</ArticleId><ArticleId IdType="pubmed">20071486</ArticleId></ArticleIdList></Reference><Reference><Citation>Davison, A. J. &amp; Scott, J. E. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol.67, 1759â1816 (1986).</Citation><ArticleIdList><ArticleId IdType="pubmed">3018124</ArticleId></ArticleIdList></Reference><Reference><Citation>Takada, T., Suzutani, M., Yoshida, I., Matoba, M. &amp; Azuma, M. Identification of varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site-less region. J. Clin. Microbiol.33, 658â660 (1995).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC228009</ArticleId><ArticleId IdType="pubmed">7751373</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenac RoviÅ¡, T. et al. Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection. J. Virol.87, 943â954 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3676123</ArticleId><ArticleId IdType="pubmed">23596286</ArticleId></ArticleIdList></Reference><Reference><Citation>Storlie, J., Maresova, L., Jackson, W. &amp; Grose, C. Comparative analyses of the 9 glycoprotein genes found in wild-type and vaccine strains of varicella-zoster virus. J. Infect. Dis.197, 49â53 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18419408</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo, C., Suen, J., Sommer, M. &amp; Arvin, A. Characterization of Varicella-Zoster virus glycoprotein K (open reading frame 5) and its role in virus growth. J. Virol.73, 4197â4207 (1999).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC104199</ArticleId><ArticleId IdType="pubmed">10196316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross, J., Williams, M. &amp; Cohen, J. I. Disruption of the varicella-zoster virus dUTPase and the adjacent ORF9A gene results in impaired growth and reduced syncytia formation in vitro. Virology. 234, 186â195 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9268149</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinchington, P. R. et al. The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka). J. Virol.64, 4540â4548 (1990).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC247925</ArticleId><ArticleId IdType="pubmed">2166829</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffat, J. F. et al. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol.72, 965â974 (1998).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC124567</ArticleId><ArticleId IdType="pubmed">9444989</ArticleId></ArticleIdList></Reference><Reference><Citation>Maresova, L., Pasieka, T. J. &amp; Grose, C. Varicella-Zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression. J. Virol.75, 9483â9492 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC114515</ArticleId><ArticleId IdType="pubmed">11533210</ArticleId></ArticleIdList></Reference><Reference><Citation>Forghani, B., Ni, L. &amp; Grose, C. Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology. 199, 458â462 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">7510086</ArticleId></ArticleIdList></Reference><Reference><Citation>Vleck, S. E. et al. Structure-function analysis of varicella-zoster virus glycoprotein H identifies domain-specific roles for fusion and skin tropism. Proc. Natl. Acad. Sci. USA. 108, 18412â18417 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3215059</ArticleId><ArticleId IdType="pubmed">22025718</ArticleId></ArticleIdList></Reference><Reference><Citation>Duus, K. M. &amp; Grose, C. Multiple regulatory effects of varicella-zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH. J. Virol.70, 8961â8971 (1996).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC190993</ArticleId><ArticleId IdType="pubmed">8971025</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori, Y. &amp; Sadaoka, T. Varicella-zoster virus glycoprotein M. Curr. Top. Microbiol. Immunol.342, 147â154 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20373090</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadaoka, T., Yanagi, T., Yamanishi, K. &amp; Mori, Y. Characterization of the varicella-zoster virus ORF50 gene, which encodes glycoprotein M. J. Virol.84, 3488â3502 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2838139</ArticleId><ArticleId IdType="pubmed">20106918</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamagishi, Y. et al. Varicella-Zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread. J. Virol.82, 795â804 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2224567</ArticleId><ArticleId IdType="pubmed">17977964</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson, J. K. &amp; Grose, C. Complex formation facilitates endocytosis of the varicella-zoster virus gE:gI fc receptor. J. Virol.72, 1542â1551 (1998).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC124636</ArticleId><ArticleId IdType="pubmed">9445058</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo, C., Lee, J., Sommer, M., Grose, C. &amp; Arvin, A. M. The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells. Virology. 304, 176â186 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12504560</ArticleId></ArticleIdList></Reference><Reference><Citation>Loparev, V. N. et al. Global identification of three major genotypes of varicella-zoster virus: Longitudinal clustering and strategies for genotyping. J. Virol.78, 8349â8358 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC446121</ArticleId><ArticleId IdType="pubmed">15254207</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, J. et al. Genomic sequencing revealed recombination event between clade 1 and clade 2 occurs in circulating varicella-zoster virus in China. Braz. J. Microbiol.55, 125â132 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10920497</ArticleId><ArticleId IdType="pubmed">38052769</ArticleId></ArticleIdList></Reference><Reference><Citation>Camacho, J. et al. Mutations in coding and non-coding regions in Varicella-Zoster virus causing fatal hemorrhagic fever without rash in an immunocompetent patient: Case report. Infect. Dis. Ther.12, 2621â2630 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10651560</ArticleId><ArticleId IdType="pubmed">37870692</ArticleId></ArticleIdList></Reference><Reference><Citation>Varicella and herpes zoster vaccines: WHO position paper, June 2014âRecommendations. Vaccine. 34, 198â199 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26723191</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, H. et al. Metagenomic analysis of a throat swab sample collected in China on a patient infected with Varicella Zoster Virus. Sci. Rep.11, 13874 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260771</ArticleId><ArticleId IdType="pubmed">34230529</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, L., Xu, S., Maple, P. A. C., Xu, W. &amp; Brown, K. E. Differentiation between wild-type and vaccines strains of varicella zoster virus (VZV) based on four single nucleotide polymorphisms. Epidemiol. Infect.145, 2618â2625 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9148785</ArticleId><ArticleId IdType="pubmed">28748773</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen, N. J. et al. Revisiting the genotyping scheme for varicella-zoster viruses based on whole-genome comparisons. J. Gen. Virol.98, 1434â1438 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5721928</ArticleId><ArticleId IdType="pubmed">28613146</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuyang, X. et al. Investigation of a varicella aggregation epidemic in the ICU caused by nursing herpes zoster patient. Prev. Med.28, 1047â1048 (2016).</Citation></Reference><Reference><Citation>Weijun, C. Investigation and analysis of nosocomial aggregated varicella caused by herpes zoster. J. Aerosp. Med.29, 351â352 (2018).</Citation></Reference><Reference><Citation>Cuiqun, S. et al. Investigation and treatment of an outbreak of varicella caused by nursing herpes zoster patient. Chin. J. Infect. Control18, 1150â1153 (2019).</Citation></Reference><Reference><Citation>Fanfan, X. et al. Investigation of two incidents of nosocomial varicella of hospital staff originating from herpes zoster. J. Pract. Shock5, 371â374 (2021).</Citation></Reference><Reference><Citation>Wagenaar, T. R., Chow, V. T., Buranathai, C., Thawatsupha, P. &amp; Grose, C. Africa model of varicella-zoster virus evolution: Single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades. Vaccine21, 1072â1081 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12559782</ArticleId></ArticleIdList></Reference><Reference><Citation>Mengyuan, Q. I. et al. Characterization of glycoprotein genes of the Varicella Zoster Virus in six Chinese provinces. Chin. J. Virol.33, 156â162 (2017).</Citation></Reference><Reference><Citation>Mou, J. et al. Characterization analysis of gM, gL gene of varicella zoster virus in six provinces of China. Chin. J. Prev. Med.52, 419â423 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29614611</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng-jiao, H. et al. Varicella cases monitoring and epidemic strains gene polymorphism analysis in Ningbo, Zhejiang. Inter J. Epidemiol. Infect. Dis.40, 254â257 (2013).</Citation></Reference><Reference><Citation>Duus, K. M., Hatfield, C. &amp; Grose, C. Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: Analysis by laser scanning confocal microscopy. Virology210, 429â440 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7618278</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler, W. J. et al. Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus. Virology214, 531â540 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">8553555</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Valcarcel, M., Fowler, W. J., Harper, D. R., Jeffries, D. J. &amp; Layton, G. T. Induction of neutralizing antibody and T-cell responses to varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE). Vaccine. 15, 709â719 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9178473</ArticleId></ArticleIdList></Reference><Reference><Citation>Faga, B., Maury, W., Bruckner, D. A. &amp; Grose, C. Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome. Virology. 280, 1â6 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11162813</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt-Chanasit, J. et al. Novel varicella-zoster virus glycoprotein E gene mutations associated with genotypes a and D. J. Clin. Microbiol.46, 325â327 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2224269</ArticleId><ArticleId IdType="pubmed">18032615</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, L. F. et al. Sequence analysis of varicella-zoster virus gE Gene in Varicella-Zoster Virus strains with different clades. Chin. J. Virol.29, 112â118 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23757839</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Q. et al. Genetic characterization of the gE Gene of 12 Case Varicella-Zoster virus in six provinces of China. Chin. J. Virol.34, 877â883 (2018).</Citation></Reference><Reference><Citation>Grose, C. et al. Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: Evolution of genotypes with an accelerated cell spread phenotype. J. Virol.78, 6799â6807 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC421634</ArticleId><ArticleId IdType="pubmed">15194755</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar, V., Fisher, S., Forghani, B. &amp; Vafai, A. Nucleotide sequence analysis of varicella-zoster virus glycoprotein E epitope coding regions. Vaccine. 19, 3830â3833 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">11427254</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen, N. J. et al. Analysis of the reiteration regions (R1 to R5) of varicella-zoster virus. Virology. 546, 38â50 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9169507</ArticleId><ArticleId IdType="pubmed">32452416</ArticleId></ArticleIdList></Reference><Reference><Citation>Muir, W. B., Nichols, R. &amp; Breuer, J. Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J. Virol.76, 1971â1979 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC135920</ArticleId><ArticleId IdType="pubmed">11799191</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerboni, L. et al. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu. Mouse Model. Virol.332, 337â346 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15661165</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaves, S. S. et al. Loss of vaccine-induced immunity to varicella over time. N. Engl. J. Med.356, 1121â1129 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17360990</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, H. et al. Transmission pattern of Measles Virus circulating in China during 1993â2021: Genotyping evidence supports that China is approaching measles Elimination. Clin. Infect. Dis.76, e1140âe1149 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36037029</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>